Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- PMID: 20555067
- DOI: 10.1093/annonc/mdq160
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Similar articles
-
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of locally recurrent or metastatic breast cancer (MBC).Ann Oncol. 2005;16 Suppl 1:i10-2. doi: 10.1093/annonc/mdi816. Ann Oncol. 2005. PMID: 15888735 No abstract available.
-
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2011 Sep;22 Suppl 6:vi25-30. doi: 10.1093/annonc/mdr372. Ann Oncol. 2011. PMID: 21908499 No abstract available.
-
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2012 Oct;23 Suppl 7:vii11-9. doi: 10.1093/annonc/mds232. Ann Oncol. 2012. PMID: 22997442 No abstract available.
-
Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.Ann Oncol. 2009 May;20 Suppl 4:15-8. doi: 10.1093/annonc/mdp115. Ann Oncol. 2009. PMID: 19454439 Review. No abstract available.
-
[Treatment guideline for advanced or recurrent breast cancer].Nihon Rinsho. 2000 Apr;58 Suppl:237-45. Nihon Rinsho. 2000. PMID: 11026001 Review. Japanese. No abstract available.
Cited by
-
Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma.Drugs. 2011 Dec 24;71(18):2531-58. doi: 10.2165/11207510-000000000-00000. Drugs. 2011. PMID: 22141391 Review.
-
Recent Advances in the Enzyme-Activatable Organic Fluorescent Probes for Tumor Imaging and Therapy.ChemistryOpen. 2022 Oct;11(10):e202200137. doi: 10.1002/open.202200137. ChemistryOpen. 2022. PMID: 36200519 Free PMC article. Review.
-
Treating Elderly Patients With Hormone Receptor-Positive Advanced Breast Cancer.Clin Med Insights Oncol. 2015 Aug 24;9:65-73. doi: 10.4137/CMO.S26067. eCollection 2015. Clin Med Insights Oncol. 2015. PMID: 26339192 Free PMC article. Review.
-
Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicity.Biomaterials. 2012 Nov;33(32):8104-10. doi: 10.1016/j.biomaterials.2012.07.043. Epub 2012 Aug 9. Biomaterials. 2012. PMID: 22884683 Free PMC article.
-
The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies - a European survey.Eur J Cancer Care (Engl). 2017 Jul;26(4):e12490. doi: 10.1111/ecc.12490. Epub 2016 Apr 12. Eur J Cancer Care (Engl). 2017. PMID: 27072626 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical